首页> 外文期刊>The Journal of Nuclear Medicine >MIRD Pamphlet no. 18: Administered cumulated activity for ventilation studies.
【24h】

MIRD Pamphlet no. 18: Administered cumulated activity for ventilation studies.

机译:MIRD小册子编号18:进行通气研究的累积活动量。

获取原文
获取原文并翻译 | 示例
           

摘要

There has been no consensus on a standard calculational approach regarding the concept of administered activity in ventilation studies involving inhaled radioisotope gas or radioaerosols. This is caused in part by a lack of knowledge regarding the actual activity that enters the lung space (as opposed to activity introduced into the delivery system) and to the extended administration times (t(a)) associated with delivery protocols. METHODS: This pamphlet reviewed the three primary ventilation procedures, including rebreathing-system protocols, continuous-flow generator output techniques, and radioaerosol delivery systems. RESULTS: For each technique, an analytic expression has been derived for a new parameter called lung administered cumulated activity, A(L)(0,t(a)), which is the cumulated activity in the lungs during the administration phase. In addition, another potentially useful parameter has been defined-the mean administered activity for ventilation procedures, which normalizes the administered cumulated activity in the lung over the administration period and may serve to standardize descriptions of protocols between patients and institutions. Examples are provided that illustrate these new concepts for typical ventilation protocol administration parameters. CONCLUSION: The models presented can be employed to evaluate lung administered cumulated activity for use in ventilation dose estimate reports as a function of explicit variables (e.g., spirometer volume, generator output rate, wash-in half-time, administration time). In practice, it is recommended that dose estimate reports be based on measurements of cumulated activity in the lung over the administration period and normalized to this administered cumulated activity.
机译:在涉及吸入放射性同位素气体或放射性气溶胶的通气研究中,关于给药活性概念的标准计算方法尚未达成共识。这部分是由于对进入肺部空间的实际活动(与引入输送系统的活动相反)以及与输送协议相关的延长的给药时间(t(a))缺乏了解。方法:本手册回顾了三个主要的通气程序,包括呼吸系统协议,连续流发生器输出技术和放射性气溶胶输送系统。结果:对于每种技术,已经针对称为肺部给药的累积活性A(L)(0,t(a))的新参数导出了解析表达式,该参数是给药阶段在肺部的累积活性。此外,还定义了另一个潜在有用的参数-通气程序的平均给药活性,可以使给药期间在肺部的累积活性标准化,并且可以用于规范患者和机构之间的方案说明。提供的示例说明了典型通风协议管理参数的这些新概念。结论:所提出的模型可用于评估肺部给药的累积活动,以作为明确变量(例如肺量计的体积,发生器输出率,冲洗半时间,给药时间)的函数用于通气剂量估计报告中。在实践中,建议剂量估算报告基于在整个给药期间内肺部累积活性的测量值,并根据该累积活性进行标准化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号